Approval is supported by data from the DEVOTE study which showed the benefit of the SPINRAZA 50 mg and 28 mg regimen in both treatment-naïve and previously-treated nusinersen patients with SMA1Biogen ...
Biogen Inc. (Nasdaq: BIIB) today announced the European Commission (EC) has granted marketing authorization for a high dose ...
In Lubbock, residents face life's hiccups with humor, lighting candles for power outages and embracing the outdoors when the ...
FAT jabs have worked for millions but a new study warns users may need to stay with the pricey drugs for life – or risk ...
Potential side effects caused by the popular exercise supplement creatine include weight gain, nausea, diarrhea, muscle ...
Panelists discuss how real-world adherence to loading doses and thoughtful switching or reloading strategies can optimize durability and outcomes, particularly in undertreated patients. This segment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results